Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Small, S. Broomfield, V. Higgins (Macclesfield, United Kingdom). Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy. Eur Respir J 2012; 40: Suppl. 56, 2876

Member's Comments

No comment yet.

Related content which might interest you: Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations? Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011 Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts Source: Eur Respir J 2013; 42: 1391-1401 Year: 2013 Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients. Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Different methods to classify COPD patients into the ABCD severity groups – Preliminary results of the LQ-DMP project Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 The distribution of COPD in general practice using three different GOLD classification Source: International Congress 2018 – COPD around the world Year: 2018 2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Stability of the exacerbation pattern defined by GOLD 2017 in a real-world COPD population Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium+olodaterol trials Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Distribution of a COPD population based on the GOLD assessment framework Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Prediction of the clinical course of COPD using the old and the new GOLD classification Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines Source: Eur Respir J 2016; 47: 978-980 Year: 2016 Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011? Source: Eur Respir J 2014; 43: 1201-1203 Year: 2014 Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification Source: Eur Respir J 2013; 42: 647-654 Year: 2013